RISK FACTORS FOR PULMONARY HYPERTENSION IN SCLERODERMA
Grant number: 1038612 | Funding period: 2012 - 2014
I am a rheumatologist treating systemic sclerosis, a life threatening illness. A serious complication is high blood pressure in the lungs, or pulmonary arterial hypertension. Unfortunately this problem is often detected too late. My goal is to be able to identify those patients who will develop this condition so that they can access life saving treatment at the earliest possible time in order to improve their quality of life and increase their chance of survival.
Related publications (3)
A COMPARISON OF THE PREDICTIVE ACCURACY OF THREE SCREENING MODELS (DETECT V. ESC/ERS V. ASIG) FOR PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC SCLEROSIS
Y Hao, V Thakkar, W Stevens, K Morrisroe, D Prior, C Rabusa, P Youssef, E Gabbay, J Roddy, J Walker, J Zochling, J Sahhar, P Nash, S Lester, M Rischmueller, S Proudman, M Nikpour
INTRODUCTION: There is evidence that early screening for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) improve..
The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
Vivek Thakkar, Wendy Stevens, David Prior, Peter Youssef, Danny Liew, Eli Gabbay, Janet Roddy, Jennifer G Walker, Jane Zochling, Joanne Sahhar, Peter Nash, Susan Lester, Maureen Rischmueller, Susanna M Proudman, Mandana Nikpour
INTRODUCTION: Pulmonary arterial hypertension (PAH) is a major cause of mortality in systemic sclerosis (SSc). Screening guideline..